REFERENCES
- Kay D. Infective endocarditis. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson DJ, Martin JB, Kasper DL, et al., eds. Harrison. New York, NY: McGraw-Hill Health Professions Division, 1997: 785–91.
- Model A, Craig CP. Isolated tricuspid valve endocarditis due to Streptococcus bovis. Clin Infect Dis 1996; 22: 178–9.
- Parrillo JE, Borst GC, Mazur MH, Iannini P, Klempner MS, Moellering RC Jr, et al. Endocarditis due to resistant viridans Streptococci during oral penicillin chemoprophylaxis. N Engl J Med 1979; 300: 296–300.
- Chan P, Ogilby JD, Segal B. Tricuspid valve endocarditis. Am Heart J 1989; 117: 1140–6.
- Iwama T, Shigematsu S, Asami K, Kubo I, Kitzzume H, Tanabe S, et al. Tricuspid valve endocarditis with large vagetations in a non-drug addict without underlying cardiac disease. Intern Med 1996; 35: 203–6.
- Willcox MDP. Potential pathogenic properties of members of the Streptococcus milleri group in relation to the production of endocarditis and abscesses. J Med Microbiol 1995; 43: 405–10.
REFERENCES
- Bergogne-Bérézin E. The increasing significance of outbreaks of Acinetobacter spp.; the need for control and new agents. J Hosp Infect 1995; 30 Suppl: 441–52.
- Seifert H, Richter W, Pulverer G. Clinical and bacteriological features of relapsing shunt-associated meningitis due to Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 1995; 14: 130–4.
- Seifert H, Schulze A, Baginski R, Pulverer G. Comparison of four different methods for epidemiologic typing of Acinetobacter baumannii. J Clin Microbiol 1994; 32: 1816–9.
- Siegman-Igra Y, Bar-Yosef S, Gorea A, Avram J. Nosocomial Acinetobacter meningitis secondary to invasive procedures: report of 25 cases and review. Clin Infect Dis 1993; 17: 843–9.
- Sanchez JF, Sanz-Hospital J, Guerrero A, Martínez-Beltrán J, Quereda C. Curación con imipenem-cilastatino de una meningitis por Acinetobacter calcoaceticus. Enferm Infecc Microbiol Clin 1991; 9: 512–3.
- Yogev R. Cerebrospinal fluid shunt infections: a personal view. Ped Infect Dis 1985; 4: 113–8.
- Urban C, Go E, Mariano N, Berger BJ, Avraham I, Rubin D, Rahal JJ. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J Infect Dis 1993; 167: 448–51.
- Tankovic J, Legrand P, De Gatines G, Chemineau V, Brun-Buisson C, Duval J. Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods. J Clin Microbiol 1994; 32: 2677–81.
- Paton R, Miles RS, Hood J, Amyes SGB. ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents 1993; 2: 81–8.
- Sato K, Nakae T. Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance. J Antimicrob Chemother 1991; 28: 35–45.
- Gerhlein M, Leying H, Cullmann W, Wendt S, Opferkuch W. Imipenem resistance in Acinetobacter baumannii is due to altered penicillin-binding proteins. Chemotherapy 1991; 37: 405–12.
- Masuda N, Ohya S. Cross resistance to meropenem, cephems and quinolones in P. aeruginosa. Antimicrob Agents Chemother 1992; 36: 1847–51.
- Villar HE, Laurino G, Arena MF, Hoffman M. Selección de mutantes resistentes y actividad bacteriostática y bactericida de meropenem e imipenem frente a Acinetobacter spp. Enferm Infec Microbiol Clin 1997; 15: 140–3.